XYNTHA® Solofuse Lyophilized Powder for Solution in Prefilled Dual-chamber Syringe How Supplied/Storage and Handling

(antihemophilic factor [Recombinant])

16 HOW SUPPLIED/STORAGE AND HANDLING

How Supplied

Each XYNTHA SOLOFUSE Kit contains: one plunger rod for assembly, one sterile infusion set, two alcohol swabs, one bandage, one gauze pad, one vented sterile cap, and one package insert. The drug product, diluents for injection and the rest of components included within the XYNTHA 250, 500, 1000, 2000, or 3000 International Units kit are free from natural rubber and natural rubber latex.

XYNTHA SOLOFUSE is supplied in a kit that includes the XYNTHA lyophilized powder containing nominally 250, 500, 1000, 2000 or 3000 IU and 4 mL 0.9 % Sodium Chloride solution for reconstitution in a prefilled dual-chamber syringe:

XYNTHA SOLOFUSE Kit
Nominal StrengthFill Size Color IndicatorKit NDC #
250 International UnitsYellow58394-022-03
500 International UnitsBlue58394-023-03
1000 International UnitsGreen58394-024-03
2000 International UnitsRed58394-025-03
3000 International UnitsGray58394-016-03

Actual factor VIII activity in International Units is stated on the label of each XYNTHA SOLOFUSE.

Storage and Handling

Product as Packaged for Sale:

  • Store XYNTHA SOLOFUSE under refrigeration at a temperature of 2° to 8°C (36° to 46°F) for up to 36 months from the date of manufacture until the expiration date stated on the label.
  • Within the expiration date, XYNTHA SOLOFUSE also may be stored at room temperature not to exceed 25°C (77°F) for up to 3 months.
  • Clearly record the starting date at room temperature storage in the space provided on the outer carton. At the end of the 3-month period, immediately use or discard the product. Do not put the product back into the refrigerator.
  • Do not use XYNTHA SOLOFUSE after the expiration date stated on the label or after 3 months when stored at room temperature, whichever is earlier.
  • Do not freeze. (Freezing may damage the XYNTHA SOLOFUSE.)
  • During storage, avoid prolonged exposure of XYNTHA SOLOFUSE to light.
  • Store the reconstituted solution at room temperature prior to administration. Administer XYNTHA SOLOFUSE within 3 hours after reconstitution or after removal of the grey rubber tip cap from the product.

Find XYNTHA® Solofuse Lyophilized Powder for Solution in Prefilled Dual-chamber Syringe medical information:

Find XYNTHA® Solofuse Lyophilized Powder for Solution in Prefilled Dual-chamber Syringe medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

XYNTHA® Solofuse Lyophilized Powder for Solution in Prefilled Dual-chamber Syringe Quick Finder

Medication Guide

Health Professional Information

How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

How Supplied

Each XYNTHA SOLOFUSE Kit contains: one plunger rod for assembly, one sterile infusion set, two alcohol swabs, one bandage, one gauze pad, one vented sterile cap, and one package insert. The drug product, diluents for injection and the rest of components included within the XYNTHA 250, 500, 1000, 2000, or 3000 International Units kit are free from natural rubber and natural rubber latex.

XYNTHA SOLOFUSE is supplied in a kit that includes the XYNTHA lyophilized powder containing nominally 250, 500, 1000, 2000 or 3000 IU and 4 mL 0.9 % Sodium Chloride solution for reconstitution in a prefilled dual-chamber syringe:

XYNTHA SOLOFUSE Kit
Nominal StrengthFill Size Color IndicatorKit NDC #
250 International UnitsYellow58394-022-03
500 International UnitsBlue58394-023-03
1000 International UnitsGreen58394-024-03
2000 International UnitsRed58394-025-03
3000 International UnitsGray58394-016-03

Actual factor VIII activity in International Units is stated on the label of each XYNTHA SOLOFUSE.

Storage and Handling

Product as Packaged for Sale:

  • Store XYNTHA SOLOFUSE under refrigeration at a temperature of 2° to 8°C (36° to 46°F) for up to 36 months from the date of manufacture until the expiration date stated on the label.
  • Within the expiration date, XYNTHA SOLOFUSE also may be stored at room temperature not to exceed 25°C (77°F) for up to 3 months.
  • Clearly record the starting date at room temperature storage in the space provided on the outer carton. At the end of the 3-month period, immediately use or discard the product. Do not put the product back into the refrigerator.
  • Do not use XYNTHA SOLOFUSE after the expiration date stated on the label or after 3 months when stored at room temperature, whichever is earlier.
  • Do not freeze. (Freezing may damage the XYNTHA SOLOFUSE.)
  • During storage, avoid prolonged exposure of XYNTHA SOLOFUSE to light.
  • Store the reconstituted solution at room temperature prior to administration. Administer XYNTHA SOLOFUSE within 3 hours after reconstitution or after removal of the grey rubber tip cap from the product.
Prescribing Information
Download Prescribing Information

Health Professional Information

How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

How Supplied

Each XYNTHA SOLOFUSE Kit contains: one plunger rod for assembly, one sterile infusion set, two alcohol swabs, one bandage, one gauze pad, one vented sterile cap, and one package insert. The drug product, diluents for injection and the rest of components included within the XYNTHA 250, 500, 1000, 2000, or 3000 International Units kit are free from natural rubber and natural rubber latex.

XYNTHA SOLOFUSE is supplied in a kit that includes the XYNTHA lyophilized powder containing nominally 250, 500, 1000, 2000 or 3000 IU and 4 mL 0.9 % Sodium Chloride solution for reconstitution in a prefilled dual-chamber syringe:

XYNTHA SOLOFUSE Kit
Nominal StrengthFill Size Color IndicatorKit NDC #
250 International UnitsYellow58394-022-03
500 International UnitsBlue58394-023-03
1000 International UnitsGreen58394-024-03
2000 International UnitsRed58394-025-03
3000 International UnitsGray58394-016-03

Actual factor VIII activity in International Units is stated on the label of each XYNTHA SOLOFUSE.

Storage and Handling

Product as Packaged for Sale:

  • Store XYNTHA SOLOFUSE under refrigeration at a temperature of 2° to 8°C (36° to 46°F) for up to 36 months from the date of manufacture until the expiration date stated on the label.
  • Within the expiration date, XYNTHA SOLOFUSE also may be stored at room temperature not to exceed 25°C (77°F) for up to 3 months.
  • Clearly record the starting date at room temperature storage in the space provided on the outer carton. At the end of the 3-month period, immediately use or discard the product. Do not put the product back into the refrigerator.
  • Do not use XYNTHA SOLOFUSE after the expiration date stated on the label or after 3 months when stored at room temperature, whichever is earlier.
  • Do not freeze. (Freezing may damage the XYNTHA SOLOFUSE.)
  • During storage, avoid prolonged exposure of XYNTHA SOLOFUSE to light.
  • Store the reconstituted solution at room temperature prior to administration. Administer XYNTHA SOLOFUSE within 3 hours after reconstitution or after removal of the grey rubber tip cap from the product.

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.